As of June 8, 2025, Lexagene Holdings Inc (LXG.V) reports a EV/EBITDA of -0.80.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Lexagene Holdings Inc's EV/EBITDA to Peers
To better understand Lexagene Holdings Inc's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Lexagene Holdings Inc (LXG.V) | -0.80 |
| IDEXX Laboratories Inc (IDXX) | 33.84 |
| SANUWAVE Health Inc (SNWV) | 22.29 |
| Zosano Pharma Corp (ZSAN) | 0.19 |
| Beyond Air Inc (XAIR) | -0.24 |
| Ekso Bionics Holdings Inc (EKSO) | -0.84 |
Compared to its competitors, Lexagene Holdings Inc's EV/EBITDA is among the highest compared to peers, suggesting the market values the company at a premium, possibly due to growth expectations.